Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria
AssigneeWyeth Holdings Corporation
InventorBenjamin J. Metcalf
Life of this patent
Estimating the term…
Abstract
The expression of the lipidated form of the peptidoglycan-associated protein (PAL) of gram-negative bacteria is achieved through the use of a plasmid containing a tightly regulated promoter. A bacterial host cell is transformed, transduced or transfected with such a plasmid. The host cell is then cultured under conditions such that the lipidated recombinant PAL is expressed. The lipidated recombinant PAL is included in an antigenic composition administered to a mammalian host to immunize against a gram-negative bacterium.
Claims5
A method of producing a recombinant lipidated peptidoglycan-associated lipoprotein (PAL), which comprises transforming, transducing or transfecting a bacterial host cell with a plasmid containing a tightly regulated promoter, wherein said promoter is an arabinose inducible promoter operatively linked to an isolated and purified DNA sequence that encodes a PAL of gram-negative bacteria, and culturing the host cell under conditions which permit the expression of said recombinant lipidated PAL by the host cell.
A method of producing a recombinant lipidated peptidocilycan-associated lipoprotein (PAL), which comprises transforming, transducing or transfecting a bacterial host cell with a T7 promoter, wherein said T7 promoter is operatively linked to an isolated and purified DNA sequence that encodes a PAL of gram-negative bacteria, and culturing the host cell under conditions which permit the expression of said recombinant lipidated PAL by the host cell, wherein expression of the recombinant lipidated PAL is under the control of only the T7 promoter.
Dependencies are inferred from the claim text.